ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag public health funding culture bioethics

Of Bioethics And Embryos
Brigid LM Hogan | Feb 5, 1995 | 2 min read
May I suggest that readers compare the lofty statements made by "premier" bioethicist Arthur Caplan in his interview with The Scientist (Oct. 17, 1994, page 12) with his superficial, ill- considered, and alarmist comments on the recent recommendations of the National Institutes of Health Human Embryo Panel, made in a syndicated column published in the St. Paul Pioneer Press on Oct. 13, 1994. For example, Caplan states that the panel recommends federal funding for studies on human parthenotes (
photo of a researcher looking in a microscope fertilising an egg via intracytoplasmic sperm injection.
Human Stem Cell Research Guidelines Updated
Ruth Williams | May 26, 2021 | 5 min read
Removal of the 14-day limit for culturing human embryos is one of the main changes in the revised recommendations from the International Society for Stem Cell Research.
japan flag chimera animal research
Bioethicists Concerned over Japan’s Chimera Embryo Regulations
Katarina Zimmer | Apr 4, 2019 | 5 min read
Many researchers see the move to relax the rules as a welcome change, yet some are worried the revisions don’t take public concerns enough into consideration.
Hard and Harder
Michael K. Gusmano | Jun 5, 2011 | 4 min read
The path to eradicating malaria in Africa involves much more than just a vaccine.
human-animal chimeric embryo, chimera, animal studies, pigs, organ transplant, induced pluripotent stem cells, survey, attitudes, public support
Majority of Respondents Support Chimeric Animal Research: Survey
Amanda Heidt | Oct 1, 2020 | 4 min read
Almost 60 percent of people in a new study on attitudes in the US felt comfortable using animals to grow human organs from induced pluripotent stem cells.
Stem Cells: Steady Momentum Toward Funding
Ted Agres | Sep 16, 2001 | 6 min read
Federal funding for research involving human embryonic stem cells (ESCs) is moving closer to reality as the Bush administration rushes to finalize a public registry of approved cell line providers. In late August, the National Institutes of Health announced 10 organizations that it said had developed 64 stem cell lines that meet all the criteria for federal funding (see table). Nevertheless, some licensing and patent issues need to be resolved and new and potentially complicating questions are e
Dealing with Unethical or Illegal Conduct in Higher Education
Anna Azvolinsky | Nov 1, 2017 | 8 min read
Investigations into cases of wrongdoing by professors are increasingly in the public eye. But are colleges and universities doing enough to deal with the problem?
A Look Back At NBAC
Eugene Russo | Oct 10, 1999 | 9 min read
Despite the presence of Hurricane Floyd and the resulting absence of more than half of the members, the National Bioethics Advisory Commission (NBAC) convened its 34th meeting Sept. 16-17 in Arlington, Va. The location of the meeting--a modest, drab hotel conference room--belied the serious subject matter of the day: "international bioethics," a preliminary consideration of bioethical regulations for research that runs between borders and cultures. It's the latest of an array of tough topics t
No decision on stem cells
Eugene Russo(erusso@the-scientist.com) | Jan 15, 2004 | 3 min read
US President's Council on Bioethics takes no position in 400-page report
Q&A: NIH Brokers HeLa Genome Deal
Bob Grant | Aug 6, 2013 | 6 min read
Officials at the government agency hammer out an agreement with the Lacks family to provide restricted access to genomes of their relative’s unwittingly donated cells.

Run a Search

ADVERTISEMENT